The Sackler family, owners of OxyContin maker Purdue Pharma, have agreed to a $7.4 billion settlement to resolve lawsuits over the opioid crisis. The deal, which involves Purdue Pharma, the Sackler family, and various state attorneys general, replaces a previous settlement that was rejected by the U.S. Supreme Court. The new agreement requires the Sacklers to pay up to $6.5 billion and relinquish ownership of the company, with an additional $900 million to be paid by the company itself.
The settlement marks one of the largest reached in the opioid crisis lawsuits, with funds intended to address the impact of the epidemic and provide support to affected communities. While some state attorneys general have welcomed the deal, others are still reviewing it. The agreement also includes provisions for compensating victims and setting aside funds for future settlements. The resolution of this long legal battle is seen as a step towards holding accountable those responsible for the opioid crisis.
Source
Note: The image is for illustrative purposes only and is not the original image of the presented article.